These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21364588)

  • 1. Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients.
    Wong SC; Ng SS; Cheung MT; Luk LY; Chan CM; Cheung AH; Lee VH; Lai PB; Ma BB; Hui EP; Lam MY; Au TC; Chan AT
    Br J Cancer; 2011 Mar; 104(6):1000-6. PubMed ID: 21364588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
    Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
    Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
    Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
    Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
    Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
    Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of CDX2 in colorectal cancers.
    Choi BJ; Kim CJ; Cho YG; Song JH; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
    APMIS; 2006 Jan; 114(1):50-4. PubMed ID: 16499661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
    Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
    Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal and Phosphatase of Regenerating Liver-3 Status in Circulating Tumor Cells May Serve as a Crucial Prognostic Marker for Assessing Relapse or Metastasis in Postoperative Patients With Colorectal Cancer.
    Su P; Lai W; Liu L; Zeng Y; Xu H; Lan Q; Chu Z; Chu Z
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00265. PubMed ID: 33512811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer.
    Tsai WS; You JF; Hung HY; Hsieh PS; Hsieh B; Lenz HJ; Idos G; Friedland S; Yi-Jiun Pan J; Shao HJ; Wu JC; Lai JM; Chang SE; Mei R; Watson D; Javey M; Nimgaonkar A
    Clin Transl Gastroenterol; 2019 Oct; 10(10):e00088. PubMed ID: 31663904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.
    Tot T
    Med Sci Monit; 2004 May; 10(5):BR139-43. PubMed ID: 15114262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinoma.
    Reggiani Bonetti L; Lionti S; Vitarelli E; Barresi V
    Virchows Arch; 2017 Dec; 471(6):731-741. PubMed ID: 28819729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of circulating tumor cells lacking cytokeratins in metastatic breast cancer patients.
    Zhao L; Li P; Li F; Yang Y; Liu N; Cai L
    J Cancer Res Ther; 2013; 9(1):29-37. PubMed ID: 23575071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of Cdx2 protein in colorectal cancer].
    Pack JH; Kim TD; Oh HA; Lee EJ; Kim JW; Jang BI; Kim TN; Jung MK; Bae YK
    Korean J Gastroenterol; 2005 Sep; 46(3):204-10. PubMed ID: 16179840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of homeodomain protein CDX2 in colorectal adenoma and adenocarcinoma.
    Bakaris S; Cetinkaya A; Ezberci F; Ekerbicer H
    Histol Histopathol; 2008 Sep; 23(9):1043-7. PubMed ID: 18581275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis.
    Sivagnanasundaram S; Islam I; Talbot I; Drummond F; Walters JR; Edwards YH
    Br J Cancer; 2001 Jan; 84(2):218-25. PubMed ID: 11161380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer.
    Xu W; Zhu Y; Shen W; Ding W; Wu T; Guo Y; Chen X; Zhou M; Chen Y; Cui L; Du P
    J Int Med Res; 2019 May; 47(5):1829-1842. PubMed ID: 30616445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.
    Bae JM; Lee TH; Cho NY; Kim TY; Kang GH
    World J Gastroenterol; 2015 Feb; 21(5):1457-67. PubMed ID: 25663765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.
    Fan Z; Li J; Dong B; Huang X
    Clin Cancer Res; 2005 Sep; 11(17):6162-70. PubMed ID: 16144916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study.
    Garrigós N; Gallego J; Guillén-Ponce C; Guaraz P; García-Bautista M; Castillejo A; Gómez-Martínez A; Carrato A; Rodríguez-Lescure A; Soto JL
    Clin Transl Oncol; 2010 Feb; 12(2):142-7. PubMed ID: 20156783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
    Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
    World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.